Multiple myeloma hopeful carfilzomib shows promise in phase I/II trial
20:48 EDT 11 Jun 2012 | Pharmaceutical Journal
Carfilzomib, a second-generation proteasome inhibitor, in combination with lenalidomide and low-dose dexamethasone...
Original Article: Multiple myeloma hopeful carfilzomib shows promise in phase I/II trial
More From BioPortfolio on "Multiple myeloma hopeful carfilzomib shows promise in phase I/II trial"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
